FDA Approved: VOSEVI — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VOSEVI (sofosbuvir/velpatasvir/voxilaprevir) from Gilead Sciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• VOSEVI (sofosbuvir/velpatasvir/voxilaprevir)

Snippet

SUPPL AP for VOSEVI (SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR)